EGFR and non-small cell lung carcinoma: A 76-gene signature associated with epithelial-mesenchymal transition was generated from gene expression profiles of cell lines and tissues of NSCLC patients, and proposed to predict resistance to EGFR and PI3K inhibitors [124].